Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk-Reference-Cited by-同舟云学术

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk

Published:2023-03 Issue: Volume:39 Page:100567
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Hoegen Philipp,Katsigiannopulos Efthimios^ORCID,Buchele Carolin,Regnery Sebastian^ORCID,Weykamp Fabian,Sandrini Elisabetta,Ristau Jonas^ORCID,Liermann Jakob^ORCID,Meixner Eva^ORCID,Forster Tobias,Renkamp C. Katharina,Schlüter Fabian,Rippke Carolin^ORCID,Debus Jürgen,Klüter Sebastian^ORCID,Hörner-Rieber Juliane

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference42 articles.

1. Metastases in carcinoma. Analysis of 1000 autopsied cases;Abrams;Cancer,1950

2. Metastatic carcinoma of the adrenal;Bullock;Am J Med Sci,1953

3. Stereotactic body radiation therapy of adrenal metastases: a pooled meta-analysis and systematic review of 39 studies with 1006 patients;Chen;Int J Radiat Oncol Biol Phys,2020

4. Metastatic tumours of the adrenal glands: A 30-year experience in a teaching hospital;Lam;Clin Endocrinol (Oxf),2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions – dosimetric impact and how to detect its extent in advance;Radiation Oncology;2024-06-25

2. Clinical Outcomes of Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Adrenal Metastases from a Single Institution;Cancers;2024-06-19

3. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases;Clinical and Translational Radiation Oncology;2024-05

4. Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases;Clinical and Translational Radiation Oncology;2024-03

5. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer;Frontiers in Oncology;2024-02-15